Announcements Trials
Browse Landscape

Phase

Phase 3 17Phase 1 17Phase 2 8Phase 1/2 7Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor Cancer 1

Interventions

Mammography 12Radiofrequency Ablation 9Blood Specimen Collection 9Standard of Care 8Drug Delivery Systems 8Colonoscopy 8Uterine Myomectomy 6Robotic Surgical Procedures 6Colposcopy 6Biopsy 6Proton Therapy 5Inositol 5Cryosurgery 5Therapeutics 4Surgical Procedures, Operative 4Radiotherapy 4Leukapheresis 4Food 4Drug Therapy 4Cryotherapy 4Cisplatin 4CF regimen 4Brachytherapy 4pegylated granulocyte colony-stimulating factor 3exemestane 3epigallocatechin gallate 3Uterine Artery Embolization 3Sunitinib 3Paclitaxel 3Oxaliplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × trifluridine tipiracil drug combination × Clear all
NCT07492173 2026-03-25

Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans

Shandong New Time Pharmaceutical Co., LTD

Phase NA Completed
76 enrolled
Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡